Month: May 2024

SAN DIEGO, May 23, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), global leader in safe and high-performance energy storage solutions, today announced that, in keeping with the Company’s recent efforts to reduce its cash consumption, KULR’s compensation committee approved a voluntary request by CEO Michael Mo to reduce the cash component of his compensation by 33% and, believing in the future of KULR, to instead grant him an equity incentive grant that does not vest for 12 months from such grant date. The strategic move ensures one-third of Mr. Mo’s salary going forward is provided at market value of the Company’s stock, further aligning his interests with those of shareholders. With this revised compensation model, the CEO’s benefits will directly...

WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, today announced Colonial Electric Supply, a large, independent, family-owned-and-operated electrical distributor, has chosen Bridgeline’s HawkSearch to power product discovery for its eCommerce website using HawkSearch’s Optimizely connector. HawkSearch will elevate Colonial Electric Supply’s eCommerce strategy through AI-powered search for the distributor’s inventory, valued at over $40M. Distributors such as Colonial Electric Supply use HawkSearch to handle common B2B queries involving unit conversions or incomplete part numbers. For instance, if a customer needs a replacement bolt-down adapter for their cable puller, but the old adapter’s label is damaged and the only text remaining is ‘XD10,’...

MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the William Blair 44th Annual Growth Stock Conference on Thursday, June 6, 2024. The Company is scheduled to present at 10:00am Central Time the same day via webcast. A live audio webcast of the presentation will be available online at the investor relations page of the Company’s website at ir.neuronetics.com. About Neuronetics Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is redefining patient and physician expectations with its NeuroStar Advanced...

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, announced today that Mai-Britt Zocca, Ph.D., the company’s President and CEO, will be presenting, and both Dr. Zocca and Amy Sullivan, the company’s CFO, will be participating in one-on-one investor meetings at the Jefferies Global Healthcare Conference to be held June 4-6, 2024 in New York, NY. Presentation DetailsDate and Time: Wednesday, June 5, 2024, 7:30-7:55 AM ESTPresenter: Mai-Britt Zocca, Ph.D., President & CEOWebcast Link: https://wsw.com/webcast/jeff302/iobt/1842656 A webcast replay of the presentation will be available from the Investors section of the Company’s website at www.iobiotech.com for 90 days. About...

BOSTON, May 23, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced that the Company will present recently announced topline data from the Company’s ongoing Phase 1/2 clinical trials of INZ-701 in adults with ENPP1 Deficiency and ABCC6 Deficiency (manifesting as pseudoxanthoma elasticum, or PXE), during oral presentations at two upcoming medical conferences. Details regarding the presentations are as follows: The European Calcified Tissue Society Congress (ECTS) 2024 being held May 25-28, 2024 in Marseille, France. Title: Impact of INZ-701 on Bone and Mineral Metabolism Biomarkers and Clinical Outcomes in Adults with...

Dallas, TX, May 23, 2024 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth, hormone replacement therapies and weight loss is excited to announce that it has engaged renown international performance marketing company, Crakmedia to champion the Company’s ongoing creative and digital marketing initiatives. Based in Quebec City, Canada, Crakmedia is a leader in performance marketing, web development and traffic monetization. Digital ads on the Crakmedia network are seen up to 1.5 billion times a day in over 150 countries and territories. The company will also use Crakmedia’s owned and operated cost-per-acquisition (CPA) network to manage...

SOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced it will participate in the TD Cowen 5th Annual Oncology Innovation Summit. TD Cowen 5th Annual Oncology Innovation SummitTuesday, May 28, 20249:30am PT/12:30pm ET The webcast will be posted to the Company’s website at www.allogene.com under the Investors tab in the News and Events section. Following a live webcast, a replay will be available on the Company’s website for approximately 30 days. About Allogene TherapeuticsAllogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development...

NANO Nuclear joins 127 global nuclear energy and technology companies to support the goal of tripling global nuclear energy capacity by 2050 New York, N.Y., May 23, 2024 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear”), an emerging vertically integrated microreactor and advanced nuclear technology company led by a world-class nuclear engineering team developing proprietary, portable, and clean energy solutions, is pleased to announce that is has committed its support to the World Nuclear Association’s Net Zero Nuclear (“NZN”) initiative. Partners of the initiative, including other U.S. corporations such as Uranium Energy Corp. and Centrus Energy Corp., recognize that nuclear generation is the largest source of clean, low-carbon electricity in member countries of the Organisation for Economic Co-operation...

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today unveiled key performance indicators from its United Kingdom operations. These indicators have contributed to the Company’s growth as the drug screening industry continues to combat drug test cheating and searches for simpler, faster, non-invasive, and more cost-effective solutions. For the nine months ended March 31, 2024, total revenue was, as previously reported, approximately $2.38 million, an increase of 193% year-over-year, of which the UK accounted for approximately 93% of revenue. During the nine-month period, the percentage of higher margin cartridge revenue accounted for approximately 49% of total revenue. As...